![]() |
|
|
Vol. 30, Issue 6, 739-746, June 2002
National Research Laboratory, College of Pharmacy and
Research Institute of Pharmaceutical Sciences, Seoul National
University (H.C.C., M.G.L., S.G.K.); and College of Dentistry,
Kangnung National University, South Korea (S.H.K)
A number of xenobiotics and certain pathophysiological situations
cause the induction of CYP2E1. The present study was designed to
establish the role of plasma urea nitrogen and L-arginine
on hepatic CYP2E1 expression in rats or rats with acute renal failure. Exposure of rats to a single intravenous dose of 5 mg/kg uranyl nitrate
caused renal failure in 5 days (ARF), as evidenced by increases in
plasma urea nitrogen level and kidney to body weight ratio. Northern
and Western blot analyses revealed that hepatic CYP2E1 was 2- to 4-fold
induced by ARF. Treatment of rats with either 10% glucose in drinking
water for 5 days following a single injection of uranyl nitrate or two
injections of recombinant growth hormone (5 units/kg, s.c., twice a
day) on the 4th day after uranyl nitrate injection reduced both the
rise in plasma urea nitrogen and the induction of CYP2E1. Exposure of
rats to urea (~225 mg/kg/day) in drinking water for 1 to 3 day(s)
resulted in significant increases in CYP2E1 mRNA and protein.
Furthermore, perfusion of the liver with 25 mM urea for 24 h
resulted in CYP2E1 induction with an increase in the mRNA. The levels
of CYP2E1 protein and mRNA were increased in rats perfused with 25 mM
L-arginine for 24 h (i.e., a 4-fold increase). Hence,
L-arginine, which is irreversibly hydrolyzed to urea and
ornithine by arginase, also induced hepatic CYP2E1. The results of the
present study provided evidence that increases in plasma urea in
conjunction with L-arginine metabolism lead to the
induction of CYP2E1 in the liver.
This article has been cited by other articles:
![]() |
Y. J. Moon, A. K. Lee, H. C. Chung, E. J. Kim, S. H. Kim, D. C. Lee, I. Lee, S. G. Kim, and M. G. Lee EFFECTS OF ACUTE RENAL FAILURE ON THE PHARMACOKINETICS OF CHLORZOXAZONE IN RATS Drug Metab. Dispos., June 1, 2003; 31(6): 776 - 784. [Abstract] [Full Text] [PDF] |
||||